TrialJournal for immunotherapy of cancer2019

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.

Harm Westdorp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.